학술논문

In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts
Document Type
Article
Source
In Experimental Hematology April 2024 132
Subject
Language
ISSN
0301-472X